迈克生物(300463)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300463 迈克生物

已收盘 01-12 15:00:00

{"stockData":{"symbol":"300463","market":"SZ","secType":"STK","nameCN":"迈克生物","latestPrice":11.91,"timestamp":1768201425000,"preClose":11.77,"halted":0,"volume":9608198,"delay":0,"changeRate":0.0119,"floatShares":492000000,"shares":605000000,"eps":-0.1943,"marketStatus":"已收盘","change":0.14,"latestTime":"01-12 15:00:00","open":11.77,"high":11.95,"low":11.74,"amount":114000000,"amplitude":0.0178,"askPrice":11.91,"askSize":66,"bidPrice":11.9,"bidSize":25,"shortable":0,"etf":0,"ttmEps":-0.1943,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768267800000},"marketStatusCode":5,"adr":0,"adjPreClose":11.77,"symbolType":"stock","openAndCloseTimeList":[[1768181400000,1768188600000],[1768194000000,1768201200000]],"highLimit":12.95,"lowLimit":10.59,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":604666624,"isCdr":false,"pbRate":1.13,"roa":"--","roe":"0.58%","epsLYR":0.2091,"committee":-0.3829,"marketValue":7202000000,"turnoverRate":0.0195,"status":0,"floatMarketCap":5857000000},"requestUrl":"/m/hq/s/300463","defaultTab":"news","newsList":[{"id":"2602546121","title":"迈克生物（300463）披露新产品取得产品注册证书，1月12日股价上涨1.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602546121","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602546121?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:38","pubTimestamp":1768228695,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘，迈克生物报收于11.91元，较前一交易日上涨1.19%，最新总市值为72.02亿元。该股当日开盘11.77元，最高11.95元，最低11.74元，成交额达1.14亿元，换手率为1.95%。公告指出，新产品注册证的取得有助于丰富公司产品线，提升市场竞争力，对公司未来经营产生积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200037586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","BK0028","BK0046","300463"],"gpt_icon":0},{"id":"2601809780","title":"迈克生物（300463）披露新产品取得产品注册证书，1月7日股价下跌1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601809780","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601809780?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:23","pubTimestamp":1767795793,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，迈克生物报收于11.41元，较前一交易日下跌1.13%，最新总市值为68.99亿元。该股当日开盘11.55元，最高11.55元，最低11.4元，成交额达7243.29万元，换手率为1.28%。公司近日发布公告称，迈克生物股份有限公司近日收到国家药品监督管理局颁发的《医疗器械注册证》，产品名为交叉配血质控品，注册类别为Ⅲ类，有效期自2025年12月31日至2030年12月30日。新产品注册证的取得丰富了公司产品线，有助于提升市场竞争力和未来经营业绩。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700038909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0046","BK0028","300463"],"gpt_icon":0},{"id":"2601873770","title":"迈克生物(300463.SZ)取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2601873770","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601873770?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:49","pubTimestamp":1767775754,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈克生物(300463.SZ)公告，公司近日收到国家药品监督管理局颁发的《医疗器械注册证》(体外诊断试剂)，相关产品名称为：交叉配血质控品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389839.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1583","BK0012","159883","BK1574","BK0046","BK1100","BK1222","09997","300463","09996","BK0028"],"gpt_icon":0},{"id":"2595789959","title":"12月29日迈克生物发布公告，股东减持40.83万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595789959","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595789959?lang=zh_cn&edition=full","pubTime":"2025-12-29 18:01","pubTimestamp":1767002481,"startTime":"0","endTime":"0","summary":"证券之星消息，12月29日迈克生物发布公告《迈克生物:关于股东股份减持计划实施完成的公告》，其股东郭雷于2025年12月19日至2025年12月26日间合计减持40.83万股，占公司目前总股本的0.0675%，变动期间该股股价上涨0.17%，截止12月26日收盘报11.47元。股东增减持详情见下表：根据迈克生物2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900025121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300463","BK0046","BK0239","BK0012"],"gpt_icon":0},{"id":"2593470704","title":"迈克生物（300463）披露新产品取得产品注册证书，12月24日股价上涨0.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593470704","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593470704?lang=zh_cn&edition=full","pubTime":"2025-12-24 22:36","pubTimestamp":1766587014,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘，迈克生物报收于11.54元，较前一交易日上涨0.61%，最新总市值为69.78亿元。公司于近日发布公告称，迈克生物股份有限公司及全资子公司迈克医疗电子有限公司近日收到四川省药品监督管理局颁发的《医疗器械注册证》，涉及血气生化分析仪、尿液分析试纸条、尿液电导率分析质控品和校准品四款新产品。上述产品的注册证有效期均为2025年12月22日至2030年12月21日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400041225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","BK0046","300463","BK0028"],"gpt_icon":0},{"id":"2592943168","title":"12月19日迈克生物发布公告，股东减持9.17万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592943168","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592943168?lang=zh_cn&edition=full","pubTime":"2025-12-19 18:01","pubTimestamp":1766138514,"startTime":"0","endTime":"0","summary":"证券之星消息，12月19日迈克生物发布公告《迈克生物:关于持股5%以上股东减持股份触及1%及5%整数倍暨披露简式权益变动报告书的提示性公告》，其股东郭雷于2025年12月18日合计减持9.17万股，占公司目前总股本的0.0152%，变动期间该股股价上涨1.24%，截止12月18日收盘报11.45元。股东增减持详情见下表：根据迈克生物2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900027945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0239","BK0012","300463"],"gpt_icon":0},{"id":"2592997454","title":"迈克生物：公司自上市以来未出现亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2592997454","media":"证券日报 ","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592997454?lang=zh_cn&edition=full","pubTime":"2025-12-17 19:36","pubTimestamp":1765971360,"startTime":"0","endTime":"0","summary":"证券日报网讯 12月17日，迈克生物在互动平台回答投资者提问时表示，公司自上市以来未出现亏损，且公司所有生产经营活动均正常有序开展，详细情况请参阅公司定期报告。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-17/doc-inhccfwi9294322.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-17/doc-inhccfwi9294322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0012","BK0239","300463","BK0046","BK0028"],"gpt_icon":0},{"id":"2591938607","title":"迈克生物：两家公司无合并重组计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2591938607","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591938607?lang=zh_cn&edition=full","pubTime":"2025-12-16 17:01","pubTimestamp":1765875661,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物(300463)12月16日在投资者关系平台上答复投资者关心的问题。投资者提问：公司和迈瑞医疗什么关系，有没有业务往来，后期会不会合并重组迈克生物回复：尊敬的投资者，您好！两家公司均为医疗器械行业公司，两家公司均围绕各自的经营战略独立运营，无合并重组的计划。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600027442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300463","BK0012","BK0239","BK0046"],"gpt_icon":0},{"id":"2590596711","title":"迈克生物：9家医院已运行智慧化实验室系统","url":"https://stock-news.laohu8.com/highlight/detail?id=2590596711","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590596711?lang=zh_cn&edition=full","pubTime":"2025-12-11 17:01","pubTimestamp":1765443662,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物(300463)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问明公司流水线和智慧实验室相比同行市场占比多少，后续还有多少提升空间，预计单站年产值多少？迈克生物回复：尊敬的投资者，您好！截至今年三季度末，已有9家医院实际运行智慧化实验室系统，12家正在实施过程中，另有多家处于前期方案设计阶段。流水线与智慧化实验室区别于传统的单机，可根据不同医院的实际情况进行推出不同模块组合的定制化设计与服务，无法准确预测计算，感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100026998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300463","BK0239","BK0012","BK0028"],"gpt_icon":0},{"id":"2590867555","title":"迈克生物(300463.SZ)子公司收到一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2590867555","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590867555?lang=zh_cn&edition=full","pubTime":"2025-12-10 19:05","pubTimestamp":1765364714,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈克生物(300463.SZ)公告，公司全资子公司迈克医疗电子有限公司于近日收到四川药品监督管理局颁发的《医疗器械注册证》，产品名称为：全自动细胞形态学分析仪。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300463","BK0046","BK0239","BK0012","09996","BK1100","159883","BK0028","BK1574","BK1222","09997","BK1583"],"gpt_icon":0},{"id":"2590372641","title":"迈克生物：公司有甲型流感相关检测产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2590372641","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590372641?lang=zh_cn&edition=full","pubTime":"2025-12-10 11:33","pubTimestamp":1765337609,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物(300463)12月09日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，近期甲流严重公司是否有检测甲流的产品，生产能力如何？迈克生物回复：尊敬的投资者，您好！公司有甲型流感相关检测产品，属于快检平台产品，目前该平台对公司的销售收入贡献较小。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000013784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300463","BK0028","BK0239","BK0012"],"gpt_icon":0},{"id":"2588755737","title":"迈克生物（300463）披露新产品取得产品注册证书，12月01日股价上涨0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588755737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588755737?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:24","pubTimestamp":1764599065,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘，迈克生物报收于11.54元，较前一交易日上涨0.52%，最新总市值为69.78亿元。该股当日开盘11.54元，最高11.66元，最低11.48元，成交额达5978.4万元，换手率为1.05%。公司近日发布公告称，迈克生物股份有限公司近日收到国家药品监督管理局颁发的《医疗器械注册证》，产品名称为血型鉴定及不规则抗体筛查质控品，注册类别为Ⅲ类，有效期至2030年11月24日。新产品注册证的取得丰富了公司产品线，有助于提升市场竞争力和未来经营业绩。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100036838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0046","300463","BK0239"],"gpt_icon":0},{"id":"2588284457","title":"迈克生物(300463.SZ)：“血型鉴定及不规则抗体筛查质控品”取得产品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2588284457","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588284457?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:09","pubTimestamp":1764580170,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈克生物(300463.SZ)发布公告，公司于近日收到国家药品监督管理局颁发的《医疗器械注册证》(体外诊断试剂)，该产品为：“血型鉴定及不规则抗体筛查质控品”。血型鉴定及不规则抗体筛查质控品系公司新增质控品产品，主要用于监测实验室检测系统的稳定状态，提高检测质量。新产品取得注册证进一步丰富了公司产品项目菜单，有助于提升公司市场综合竞争力，对市场的拓展以及公司未来的经营将产生积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK0012","BK0028","BK0239","300463"],"gpt_icon":0},{"id":"2586878214","title":"迈克生物：AI技术应用于尿液血球病理项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2586878214","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586878214?lang=zh_cn&edition=full","pubTime":"2025-11-28 20:52","pubTimestamp":1764334329,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物11月27日在投资者关系平台上答复投资者关心的问题。网传所谓“DeepMind发布AI血检系统，识别13种癌症”的说法，目前并无公开记录，且缺乏任何可核实的权威来源。目前公司已将人工智能、大数据模型应用于尿液、血球、病理等项目上，公司也在探索将人工智能的技术应用于更广泛的医疗领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800036350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300463","BK0028","BK0239","BK0012"],"gpt_icon":0},{"id":"2586525932","title":"迈克生物：已实施股份回购并提升分红比例至50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586525932","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586525932?lang=zh_cn&edition=full","pubTime":"2025-11-26 20:51","pubTimestamp":1764161475,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物11月25日在投资者关系平台上答复投资者关心的问题。公司采取了回购、分红等途径提升对投资者的回报：公司已于2025年9月5日实施完成注销公司股份合计7,802,966股，约占注销前公司股本总额612,469,590股的1.28%；公司近年亦持续分红，每年分红比例不低于净利润的30%，在2024年度利润分配预案中提升分红比例至50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600035747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","300463","BK0239","BK0012"],"gpt_icon":0},{"id":"2586252892","title":"迈克生物(300463.SZ)股东郭雷拟减持不超50万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2586252892","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586252892?lang=zh_cn&edition=full","pubTime":"2025-11-26 20:44","pubTimestamp":1764161075,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈克生物(300463.SZ)发布公告，公司于近日收到公司持股5%以上股东郭雷先生出具的《关于计划减持公司股份告知函》，计划自公告披露之日起15个交易日后的三个月内进行，合计通过集中竞价方式减持不超过50万股公司股份，即不超过公司当前总股本的0.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374114.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK0239","BK0028","BK0012","300463"],"gpt_icon":0},{"id":"2585118292","title":"迈克生物：推广智慧化实验室应对行业周期压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2585118292","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585118292?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:21","pubTimestamp":1763713274,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物11月21日在投资者关系平台上答复投资者关心的问题。尽管面临市场内卷和前期投入带来的压力，业绩有所承压，但我们认为推广“智慧化实验室”是必要的市场策略，有助于公司穿越行业周期并把握结构性机会。目前，已有9家医院实际运行智慧化实验室系统，12家正在实施过程中，另有多家处于前期方案设计阶段，详细情况请关注公司定期报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100019768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300463","BK0012","BK0239","BK0046","BK0028"],"gpt_icon":0},{"id":"2583952570","title":"迈克生物：公司暂无并购重组计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2583952570","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583952570?lang=zh_cn&edition=full","pubTime":"2025-11-14 12:11","pubTimestamp":1763093460,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：公司是否有并购重组计划？迈克生物（300463.SZ）11月14日在投资者互动平台表示，公司目前暂无并购重组计划。（文章来源：每日经济新闻）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-14/doc-infxiwfa4553788.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-14/doc-infxiwfa4553788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0046","BK0012","BK0028","300463","161123"],"gpt_icon":0},{"id":"2583539014","title":"迈克生物：12+1重点出海区域包括亚太、中东非、美洲及欧盟","url":"https://stock-news.laohu8.com/highlight/detail?id=2583539014","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583539014?lang=zh_cn&edition=full","pubTime":"2025-11-13 11:36","pubTimestamp":1763005006,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物(300463)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：请问迈克生物年报里常常提到的“121”重点出海区域具体包括哪些国家？迈克生物回复：尊敬的投资者，您好！公司依据出海战略将海外国家和地区分为几大区域，“12+1”主要为海外区域的重点国家及地区：亚太区有印度尼西亚等5个国家，中东非区（EMEA）有3个国家，美洲区有4个国家及地区，以及“1”所指代的欧盟。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300016989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","FESXmain","FSXEmain","BK0028","BK0012","BK0046","300463"],"gpt_icon":0},{"id":"2583808665","title":"迈克生物：推广智慧化实验室穿越行业周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2583808665","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583808665?lang=zh_cn&edition=full","pubTime":"2025-11-13 08:42","pubTimestamp":1762994535,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物(300463)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：公司后续如何改善业绩迈克生物回复：尊敬的投资者，您好！尽管面临市场内卷和前期投入带来的压力，业绩有所承压，但我们认为推广“智慧化实验室”是必要的市场策略，有助于公司穿越行业周期并把握结构性机会。目前，已有9家医院实际运行智慧化实验室系统，12家正在实施过程中，另有多家处于前期方案设计阶段，详细情况请关注公司定期报告。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300007893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","BK0046","BK0028","300463"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768265679175,"stockEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":0.0624},{"period":"3month","weight":0.0429},{"period":"6month","weight":-0.0325},{"period":"1year","weight":-0.0199},{"period":"ytd","weight":0.0643}],"compareEarnings":[{"period":"1week","weight":0.0353},{"period":"1month","weight":0.0709},{"period":"3month","weight":0.0776},{"period":"6month","weight":0.1888},{"period":"1year","weight":0.3146},{"period":"ytd","weight":0.0495}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"迈克生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"33893人(较上一季度减少3.05%)","perCapita":"14510股","listingDate":"2015-05-28","address":"四川省成都市郫都区高新区百川路16号","registeredCapital":"60466万元","survey":"　　迈克生物股份有限公司的主营业务是体外诊断产品的研发、生产、销售和相关服务。公司的主要产品是体外诊断产品。","listedPrice":27.96},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈克生物(300463)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈克生物(300463)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈克生物,300463,迈克生物股票,迈克生物股票老虎,迈克生物股票老虎国际,迈克生物行情,迈克生物股票行情,迈克生物股价,迈克生物股市,迈克生物股票价格,迈克生物股票交易,迈克生物股票购买,迈克生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈克生物(300463)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈克生物(300463)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}